SOX4 interacts with plakoglobin in a Wnt3a-dependent manner in prostate cancer cells

BMC Cell Biology

Volumn 12, Issue , 2011, Pages

  Lai, Yu Heng ^a,b   Cheng, Jessica ^b   Cheng, Dongmei ^b   Feasel, Mattie E ^b   Beste, Kyle D ^b   Peng, Junmin ^b,c   Nusrat, Asma ^b   Moreno, Carlos S ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LEPTOMYCIN B; PLAKOGLOBIN; TRANSCRIPTION FACTOR SOX4; WNT3A PROTEIN; ANTINEOPLASTIC ANTIBIOTIC; AXIN; AXIN2 PROTEIN, HUMAN; DEAD BOX PROTEIN; DHX9 PROTEIN, HUMAN; DICER1 PROTEIN, HUMAN; DNA; RIBONUCLEASE III; SMALL INTERFERING RNA; SOX4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR PROTEIN; UNSATURATED FATTY ACID;

AMINO TERMINAL SEQUENCE; ARTICLE; AXIN2 GENE; BIOTINYLATION; BREAST CANCER; CANCER CELL; CELL NUCLEUS; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; DHX9 GENE; DICER1 GENE; DNA BINDING; GENE; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; NUCLEAR EXPORT SIGNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; PURIFICATION; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION; ACTIVE TRANSPORT; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MALE; METABOLISM; PATHOPHYSIOLOGY; PROSTATE TUMOR; PROTEIN BINDING; RNA INTERFERENCE; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIBIOTICS, ANTINEOPLASTIC; AXIN PROTEIN; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DNA; FATTY ACIDS, UNSATURATED; GAMMA CATENIN; HUMANS; MALE; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN BINDING; RIBONUCLEASE III; RNA INTERFERENCE; RNA, SMALL INTERFERING; SOXC TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 81255128256     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-12-50     Document Type: Article

References (36)

1. Schepers GE, Teasdale RD, Koopman P. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 2002, 3(2):167-170. 10.1016/S1534-5807(02)00223-X, 12194848.
2. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004, 18(9):1072-1087. 10.1101/gad.1171104, 406296, 15132997.
3. Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE. Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 1999, 4(4):487-498. 10.1016/S1097-2765(00)80200-2, 10549281.
4. Takash W, Canizares J, Bonneaud N, Poulat F, Mattei MG, Jay P, Berta P. SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 2001, 29(21):4274-4283. 10.1093/nar/29.21.4274, 60197, 11691915.
5. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, Wells JM. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 2007, 27(22):7802-7815. 10.1128/MCB.02179-06, 2169141, 17875931.
6. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997, 278(5340):1059-1064. 10.1126/science.278.5340.1059, 9353180.
7. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sorensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjot L, Orntoft T. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 2006, 66(7):3434-3442. 10.1158/0008-5472.CAN-05-3456, 16585165.
8. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, Moreno CS. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 2006, 66(8):4011-4019. 10.1158/0008-5472.CAN-05-3055, 16618720.
9. Lee CJ, Appleby VJ, Orme AT, Chan WI, Scotting PJ. Differential expression of SOX4 and SOX11 in medulloblastoma. J Neurooncol 2002, 57(3):201-214. 10.1023/A:1015773818302, 12125983.
10. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004, 101(25):9309-9314. 10.1073/pnas.0401994101, 438973, 15184677.
11. Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH, Sun YJ. Prognostic value of CRM1 in pancreas cancer. Clin Invest Med 2009, 32(6):E315.
12. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA, Copeland NG. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002, 32(1):166-174. 10.1038/ng949, 12185365.
13. Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, Russell R, DePinho RA, Lenz J, van Lohuizen M. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 2002, 32(1):160-165. 10.1038/ng956, 12185367.
14. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, Morse HC. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res 2004, 64(13):4419-4427. 10.1158/0008-5472.CAN-03-3885, 15231650.
15. Cowin P, Kapprell HP, Franke WW, Tamkun J, Hynes RO. Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell 1986, 46(7):1063-1073. 10.1016/0092-8674(86)90706-3, 3530498.
16. Peifer M, Wieschaus E. The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin. Cell 1990, 63(6):1167-1176. 10.1016/0092-8674(90)90413-9, 2261639.
17. McCrea PD, Turck CW, Gumbiner B. A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. Science 1991, 254(5036):1359-1361. 10.1126/science.1962194, 1962194.
18. Aberle H, Butz S, Stappert J, Weissig H, Kemler R, Hoschuetzky H. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci 1994, 107(Pt 12):3655-3663.
19. Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line. Oncogene 2004, 23(4):964-972. 10.1038/sj.onc.1207254, 14661054.
20. Shimizu M, Fukunaga Y, Ikenouchi J, Nagafuchi A. Defining the roles of beta-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using beta-catenin/plakoglobin-null F9 cells. Mol Cell Biol 2008, 28(2):825-835. 10.1128/MCB.02375-06, 2223424, 17984222.
21. Xu P, Duong DM, Peng J. Systematical optimization of reverse-phase chromatography for shotgun proteomics. Journal of proteome research 2009, 8(8):3944-3950. 10.1021/pr900251d, 2749476, 19566079.
22. Ramachandran S, Liu P, Young AN, Yin-Goen Q, Lim SD, Laycock N, Amin MB, Carney JK, Marshall FF, Petros JA, Moreno CS. Loss of HOXC6 Expression Induces Apoptosis in Prostate Cancer Cells. Oncogene 2005, 24(1):188-198. 10.1038/sj.onc.1207906, 15637592.
23. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 2009, 69(2):709-717. 10.1158/0008-5472.CAN-08-3415, 2629396, 19147588.
24. Holden P, Horton WA. Crude subcellular fractionation of cultured mammalian cell lines. BMC Res Notes 2009, 2:243. 10.1186/1756-0500-2-243, 2802353, 20003239.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
26. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303(5662):1378-1381. 10.1126/science.1089769, 3012624, 14988562.
27. Rieger-Christ KM, Ng L, Hanley RS, Durrani O, Ma H, Yee AS, Libertino JA, Summerhayes IC. Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 2005, 92(12):2153-2159. 10.1038/sj.bjc.6602651, 2361803, 15942628.
28. Barker DF, Campbell AM. The birA gene of Escherichia coli encodes a biotin holoenzyme synthetase. J Mol Biol 1981, 146(4):451-467. 10.1016/0022-2836(81)90042-5, 7024555.
29. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002, 22(4):1172-1183. 10.1128/MCB.22.4.1172-1183.2002, 134648, 11809808.
30. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275(5307):1784-1787. 10.1126/science.275.5307.1784, 9065401.
31. Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S. Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther 2007, 6(10):1638-1643. 10.4161/cbt.6.10.4904, 18245958.
32. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 2000, 14(11):1319-1331. 316666, 10837025.
33. Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Trope CG, Kristensen GB, Bryne M, Ann Florenes V. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol 2000, 192(4):460-469. 10.1002/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M, 11113863.
34. Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 2002, 62(9):2625-2629.
35. Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C, Heasley LE. gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 2002, 21(49):7497-7506. 10.1038/sj.onc.1205963, 12386812.
36. Hu P, Berkowitz P, O'Keefe EJ, Rubenstein DS. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus. J Invest Dermatol 2003, 121(2):242-251. 10.1046/j.1523-1747.2003.12376.x, 12880414.